Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Forte Biosciences Inc (NQ: FBRX ) 0.5950 +0.0050 (+0.85%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Forte Biosciences Inc < Previous 1 2 Next > Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules May 17, 2024 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update May 13, 2024 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update March 18, 2024 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules December 01, 2023 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update November 13, 2023 From Forte Biosciences, Inc. Via Business Wire ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting September 14, 2023 From On behalf of Concerned Stockholders of Forte Via Business Wire Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom September 06, 2023 From On behalf of Concerned Stockholders of Forte Via Business Wire Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders August 25, 2023 From On behalf of Concerned Stockholders of Forte Via Business Wire Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update August 14, 2023 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102 August 01, 2023 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules May 19, 2023 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update May 15, 2023 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update March 31, 2023 From Forte Biosciences, Inc. Via Business Wire Mr. David Gryska Appointed to Forte Biosciences Board of Directors January 12, 2023 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update November 14, 2022 From Forte Biosciences, Inc. Via Business Wire Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors November 14, 2022 From Forte Biosciences, Inc. Via Business Wire Camac Partners Condemns Forte Biosciences’ Seemingly Defensive and Unjustifiable Capital Raise August 17, 2022 From Camac Partners, LLC Via Business Wire Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update August 15, 2022 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Announces the Appointment of Dr. Hubert Chen, MD as Chief Scientific Officer and President June 07, 2022 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules June 07, 2022 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Announces First Quarter 2022 Results and Provides Business Update May 16, 2022 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. (NASDAQ:FBRX) Shareholder Notice: Investigation over Potential Wrongdoing October 27, 2021 San Diego, CA -- (SBWIRE) -- 10/27/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Forte Biosciences, Inc. Via SBWire NASDAQ:FBRX Shareholder Notice: Investigation over Potential Securities Laws Violations by Forte Biosciences, Inc. September 17, 2021 San Diego, CA -- (SBWIRE) -- 09/17/2021 -- Forte Biosciences, Inc is under investigation concerning potential securities laws violations in connection with certain financial statements. Via SBWire ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm September 08, 2021 From The Schall Law Firm Via Business Wire INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm September 06, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors With Losses to Contact the Firm September 03, 2021 From The Schall Law Firm Via Business Wire Clinical Trial of FB-401 For the Treatment of Atopic Dermatitis Fails to Meet Statistical Significance September 02, 2021 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. to Review the Second Quarter 2021 Results and Expects to Announce Topline Data From Phase 2 Clinical Trial of FB-401 for the Treatment of Atopic Dermatitis on Sept. 7 August 16, 2021 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules August 02, 2021 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules July 12, 2021 From Forte Biosciences, Inc. Via Business Wire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.